// App-Quantinova.ai

1256-180 : NEW GENERATION DRUG-ELUTING STENT SUPERIOR TO BENCHMARK XIENCE DRUG-ELUTING STENT

Researchers

Presenter

  • Masato Nakamura

Principal Investigators

  • Satoru Otsuji

  • Yoshihisa Nakagawa

  • Yuji Oikawa

  • Nobuo Shiode

  • Masatoshi Miyahara

  • Gaku Nakazawa

  • Hiroyoshi Yokoi

Medical Centers

  • Associations for Establishment of Evidence in Interventions, Minatoku, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Propel

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim